Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.
about
A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma TumorsImmunoexpression analysis and prognostic value of BLCAP in breast cancerA-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer.Expression of cyclin d1 and its association with disease characteristics in bladder cancer.MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels.Does phosphorylation of cofilin affect the progression of human bladder cancer?ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas.Proteomics in cancer biomarkers discovery: challenges and applications.Bladder cancer-associated protein is suppressed in human cervical tumors.The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.Ten Years of Proteomics in Bladder Cancer: Progress and Future Directions.Advances in porcine genomics and proteomics--a toolbox for developing the pig as a model organism for molecular biomedical research.Tissue and serum proteomic profiling for diagnostic and prognostic bladder cancer biomarkers.Noninvasive approaches for detecting and monitoring bladder cancer.Developing proteomic biomarkers for bladder cancer: towards clinical application.CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation.Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer.The need for immune biomarkers for treatment prognosis and response in genitourinary malignancies.
P2860
Q28071574-DEDA2519-41EB-429D-833B-52172D909713Q31103058-AAD11321-A59F-4744-BA1A-A01F21C12B1DQ33889216-66A660FC-0E59-4870-9727-C2C440D9B9CAQ34005450-9FE90D54-3200-49A5-BED1-C9CFDF96C104Q34045027-4D243E9F-6707-416B-80CC-18DD8F840BF7Q34572101-05CE2961-81B4-4905-924F-6C258D799CAEQ34734481-F3290778-4833-4F83-95E3-5B38668D461DQ35592114-70E20FA7-CC9A-40B5-83AC-BCAB359F6B54Q36225363-7A2F3D22-A157-4113-9CEC-888F4120FC9AQ36323508-C1271C98-680C-4E22-A240-DE4358D49980Q37610542-4FBE97CC-81C9-458F-ADED-5A2E8AD2D432Q37759974-187248B4-239D-460E-AF4F-9AA8531B47CEQ37818317-61742568-808B-41AB-A7FB-ED0164265780Q38286089-9F909841-414F-4677-B0E9-D035F374FE30Q38511509-FE23B957-9B05-4273-911B-08D7DFBBB989Q39018985-3BF57055-3137-4580-9C3F-D4065EB3152FQ47099158-724566D6-57F5-4FBB-BD1E-BA71124B8949Q49545290-51A39345-3B3C-45C5-988C-607631238A11
P2860
Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Bladder cancer-associated prot ...... arker in human bladder cancer.
@ast
Bladder cancer-associated prot ...... arker in human bladder cancer.
@en
type
label
Bladder cancer-associated prot ...... arker in human bladder cancer.
@ast
Bladder cancer-associated prot ...... arker in human bladder cancer.
@en
prefLabel
Bladder cancer-associated prot ...... arker in human bladder cancer.
@ast
Bladder cancer-associated prot ...... arker in human bladder cancer.
@en
P2093
P2860
P50
P1476
Bladder cancer-associated prot ...... marker in human bladder cancer
@en
P2093
Gita Ohlsson
Guido Sauter
Julio E Celis
Pavel Gromov
P2860
P304
P356
10.1074/MCP.M900294-MCP200
P577
2009-09-25T00:00:00Z